3D Printed Drugs Market Size Share Analysis 2022-2029

Key Players Involved in 3D Printed Drugs Market

Aprecia Pharmaceuticals

• Aprecia is the world's leading provider of commercial-scale 3DP for pharmaceutical manufacture. The company is dedicated to producing pharma-ready inventions and complementary technology platforms that enable patient-centric products and help medicine reach its full potential by addressing unmet healthcare needs.
•  Aprecia's proprietary 3DP technology includes a multi-patented, binder-jetting, manufacturing system, allowing for both Open-Bed and In-Cavity printing, as well as their advanced formulation and rapid-prototyping platforms.
• Aprecia uses its ZipDose® Technology Platform to create rapidly disintegrating oral dosage forms that are easy to take and easy to administer. 
• Aprecia licenses its exclusive technology platform to pharmaceutical partners as a means to extend product lines, improve patient reach and experience, and address FDA requirements as a pediatric delivery form. 

FabRx Ltd. 

• FabRx is a specialist biotech company, revolutionizing the manufacture of medicines using innovative 3D printing technologies
• The company was created by leading academics at University College London (UCL), with a passion for developing better medicines using 3D printing
• They believe in a world where medical treatment can be personalized to the individual needs of each patient for production on site in pharmacies or clinical trials units
• Using their patented technologies, company provide a novel and flexible platform for the production of personalized medicines

Cycle Pharmaceuticals

• Cycle Pharmaceutical is a pharmaceutical company, reimagining how drugs can benefit patients, to make their lives easier and improve their quality of life at every stage.
• Cycle has three core areas of pharmaceutical development: improving drugs (optimising an existing drug); repurposing drugs (creating a new indication for an already existing drug) and generics (reinstating generic drugs, previously available in the market).
• These three areas of focus are underpinned by formulation technology - creating new drug delivery technologies to improve the efficacy and effectiveness of drugs, allowing Cycle to give patients greater freedom and choice.
• Based in Cambridge, United Kingdom, Cycle has developed unique partnerships with renowned universities around the world. Cycle is not limited to any one disease area.

E. Merck KG

• The company engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products.
• It operates through the following segments: Pharmaceutical, Animal Health, Healthcare Services, and Alliances.
• The pharmaceutical segment includes human health pharmaceutical and vaccine products. The animal health segment discovers, develops, manufactures, and markets animal health products such as vaccines, which it sells to veterinarians, distributors, and animal producers.
• The healthcare services segment offers services and solutions that focus on engagement, health analytics, and clinical services to improve the value of care delivered to patients.
• They are committed to being the premier, research-intensive  biopharmaceutical company and are dedicated to providing leading  innovations and solutions for today and the future.

GlaxoSmithKline Plc.

• GlaxoSmithKline PLC is a global healthcare company. The Company operates through two segments: Pharmaceuticals and Vaccines
• The Company focuses on its research across six areas: Respiratory diseases, human immunodeficiency virus (HIV)/infectious diseases, Vaccines, Immuno-inflammation, Oncology and Rare diseases.
• The Company makes a range of prescription medicines and vaccines products. The Pharmaceuticals business discovers, develops and commercializes medicines to treat a range of acute and chronic diseases
• The Vaccines business provides vaccines for people of all ages from babies and adolescents to adults and older people. It has a portfolio of medicines in respiratory and HIV. Its Pharmaceuticals business includes Respiratory, HIV, Specialty products, and Classic and Established products
•  Its Vaccines business has a portfolio of over 40 pediatric, adolescent, adult, older people and travel vaccines

Glatt Pharmaceutical Services 

• Glatt offers a unique expertise and product spectrum and a comprehensive support service for pharmaceutical and related powder processing industries. 
• The support service starts with the product development for solid dosage forms and goes far beyond the required process technologies, optionally even covers the planning and installation of the plant required for said technologies. 
• Process Technology Pharma is the original and top-selling area of expertise of the Glatt brand. It includes the core business of fluidized beds for which Glatt has assumed a pioneering role and is considered a worldwide leading supplier.
• Process Technology Food, Feed & Fine Chemicals develops, plans and distributes fluidized and spouted bed systems for the food, feed and chemical industries. 
• Moreover, about 3,000 employees work for Glatt at more than 15 companies and offices all over the world

About Us:

DataM Intelligence was incorporated in the early weeks of 2017 as a Market Research and Consulting firm with just two people on board. Within a span of less than a year, we have secured more than 100 unique customers from established organizations all over the world.

For more information:

Sai Kiran

Sales Manager at DataM Intelligence

Email: [email protected]

Tel: +1 877 441 4866

Website: www.datamintelligence.com